{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:48:46Z","timestamp":1791186526295,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.humpath.2011.02.027","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T19:08:13Z","timestamp":1309979293000},"page":"1989-2000","source":"Crossref","is-referenced-by-count":22,"title":["Cross-talk between chronic lymphocytic leukemia cells and bone marrow endothelial cells: role of signal transducer and activator of transcription 3"],"prefix":"10.1016","volume":"42","author":[{"given":"Xavier","family":"Badoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bueso-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ferrajoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeev","family":"Estrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2011.02.027_bb0005","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.02.027_bb0010","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/blood.V96.9.3181","article-title":"In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells","volume":"96","author":"Chen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.02.027_bb0015","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/sj.leu.2401825","article-title":"Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia","volume":"14","author":"Kini","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.02.027_bb0020","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2002-01-0084","article-title":"Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia","volume":"100","author":"Molica","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.02.027_bb0025","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood.V97.8.2529","article-title":"Angiogenesis is increased in B-cell chronic lymphocytic leukemia","volume":"97","author":"Peterson","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.02.027_bb0030","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood.V96.2.768","article-title":"Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia","volume":"96","author":"Aguayo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.02.027_bb0035","first-page":"1106","article-title":"Vascular endothelial growth factor isoforms 121 and 165 are expressed on B-chronic lymphocytic leukemia cells","volume":"85","author":"Molica","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2011.02.027_bb0040","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/sj.leu.2402467","article-title":"B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules","volume":"16","author":"Kay","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.02.027_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.bjc.6600022","article-title":"Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia","volume":"86","author":"Molica","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2011.02.027_bb0050","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2141.1999.01752.x","article-title":"Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia","volume":"107","author":"Molica","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2011.02.027_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0145-2126(03)00256-X","article-title":"All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells","volume":"28","author":"Bairey","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2011.02.027_bb0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0145-2126(00)00139-9","article-title":"Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL)","volume":"25","author":"Aguayo","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2011.02.027_bb0065","first-page":"795","article-title":"High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia","volume":"7","author":"Ferrajoli","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2011.02.027_bb0070","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/sj.onc.1203486","article-title":"STAT signaling in the pathogenesis and treatment of leukemias","volume":"19","author":"Lin","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2011.02.027_bb0075","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1038\/sj.onc.1203476","article-title":"The role of STATs in transcriptional control and their impact on cellular function","volume":"19","author":"Bromberg","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2011.02.027_bb0080","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.4049\/jimmunol.159.11.5206","article-title":"Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase","volume":"159","author":"Yu","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2011.02.027_bb0085","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.168.1.466","article-title":"Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T\/null-cell lymphoma","volume":"168","author":"Zhang","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2011.02.027_bb0090","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1172\/JCI119869","article-title":"B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues","volume":"100","author":"Frank","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humpath.2011.02.027_bb0095","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1182\/blood-2009-10-230060","article-title":"STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells","volume":"115","author":"Hazan-Halevy","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.02.027_bb0100","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","article-title":"Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2011.02.027_bb0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.onc.1206122","article-title":"Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2011.02.027_bb0110","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1038\/sj.onc.1208719","article-title":"Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways","volume":"24","author":"Xu","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2011.02.027_bb0115","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0959-8049(02)00094-1","article-title":"Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours","volume":"38","author":"Vermeulen","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2011.02.027_bb0120","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1038\/sj.onc.1205859","article-title":"Roles of activated Src and Stat3 signaling in melanoma tumor cell growth","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2011.02.027_bb0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/(SICI)1097-0177(199905)215:1<54::AID-DVDY6>3.0.CO;2-0","article-title":"Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis","volume":"215","author":"Tomanek","year":"1999","journal-title":"Dev Dyn"},{"key":"10.1016\/j.humpath.2011.02.027_bb0130","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1182\/blood.V94.12.4011","article-title":"Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin","volume":"94","author":"Naiyer","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.02.027_bb0135","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1182\/blood-2008-10-185827","article-title":"Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting","volume":"113","author":"Kurtova","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.02.027_bb0140","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1182\/blood-2003-08-2763","article-title":"VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia","volume":"104","author":"Lee","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.02.027_bb0145","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1182\/blood-2004-10-4054","article-title":"CCL, but not normal B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium","volume":"105","author":"Till","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.02.027_bb0150","first-page":"1432","article-title":"Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia","volume":"91","author":"Smolej","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2011.02.027_bb0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1746-1596-3-16","article-title":"Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence","volume":"3","author":"Frater","year":"2008","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2011.02.027_bb0160","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1182\/blood-2008-10-185686","article-title":"Aberrant refulation of pVHL levels by microRNA promotes the HIF\/VEGF axis in CLL B cells","volume":"113","author":"Ghosh","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2011.02.027_bb0165","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3858\/emm.2008.40.5.479","article-title":"STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination","volume":"40","author":"Jung","year":"2008","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.humpath.2011.02.027_bb0170","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1096\/fj.04-3099fje","article-title":"STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells","volume":"19","author":"Jung","year":"2005","journal-title":"Faseb J"},{"key":"10.1016\/j.humpath.2011.02.027_bb0175","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1073\/pnas.92.5.1416","article-title":"Apoptosis and interleukin 7 gene expression in chronic B-lymphocytic leukemia cells","volume":"92","author":"Long","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2011.02.027_bb0180","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.humpath.2011.02.027_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.humpath.2011.02.027_bb0190","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.leu.2403631","article-title":"Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells","volume":"19","author":"Farahani","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.02.027_bb0195","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.leu.2403667","article-title":"VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance","volume":"19","author":"Lee","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2011.02.027_bb0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/PL00000776","article-title":"The CD40\/CD154 receptor\/ligand dyad","volume":"58","author":"Schonbeck","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.humpath.2011.02.027_bb0205","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/1042819031000068007","article-title":"IL-4 biology: impact on normal and leukemic CLL B cells","volume":"44","author":"Kay","year":"2003","journal-title":"Leuk Lymphoma"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681771100150X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681771100150X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T01:03:32Z","timestamp":1686186212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681771100150X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S004681771100150X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2011.02.027","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}